| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.2 | 0.0002 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.21 | 0.0003 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0004 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.16 | 0.0005 |